2017
DOI: 10.1016/j.molstruc.2016.12.056
|View full text |Cite
|
Sign up to set email alerts
|

Spectroscopic characterization and biological studies in vitro of a new silver complex with furosemide: Prospective of application as an antimicrobial agent

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
11
0
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
7

Relationship

2
5

Authors

Journals

citations
Cited by 18 publications
(14 citation statements)
references
References 41 publications
1
11
0
1
Order By: Relevance
“…The results obtained in this work demonstrated that the [Ag2(C4H4O4)] complex showed significant growth inhibition activity of the tested bacterial species, when compared with other studies that report the inhibitory activity of bacterial growth by Ag(I) complexes with several ligands, as Ag(I) with furosemide (MIC = 0.39 mmol L -1 for gram-positive bacteria strains) 32 , sulfathiazole (MIC 3.45 mmol L -1 for gram-negative bacteria and 6.90 mmol L -1 for Gram-positive bacteria strains) and sulfamethoxazole (MIC = 1.74 mmol L -1 for gram-negative bacteria and 13.9 mmol L -1 for gram-positive bacteria) 39 . The results demonstrate the potential for using the [Ag2(C4H4O4)] complex as an antibacterial drug in the future.…”
Section: Minimum Inhibitory Concentration (Mic)supporting
confidence: 55%
See 1 more Smart Citation
“…The results obtained in this work demonstrated that the [Ag2(C4H4O4)] complex showed significant growth inhibition activity of the tested bacterial species, when compared with other studies that report the inhibitory activity of bacterial growth by Ag(I) complexes with several ligands, as Ag(I) with furosemide (MIC = 0.39 mmol L -1 for gram-positive bacteria strains) 32 , sulfathiazole (MIC 3.45 mmol L -1 for gram-negative bacteria and 6.90 mmol L -1 for Gram-positive bacteria strains) and sulfamethoxazole (MIC = 1.74 mmol L -1 for gram-negative bacteria and 13.9 mmol L -1 for gram-positive bacteria) 39 . The results demonstrate the potential for using the [Ag2(C4H4O4)] complex as an antibacterial drug in the future.…”
Section: Minimum Inhibitory Concentration (Mic)supporting
confidence: 55%
“…Determination of the minimum inhibitory concentration (MIC) of the free ligand and [Ag2(C4H4O4)] was performed using different reference bacterial strains, S. aureus ATCC 25923, B. cereus ATCC 14579, E. coli ATCC 25922 and P. aeruginosa ATCC 27853, as described in CLSI 2016 31,32 . The bacterial strains were inoculated in tubes containing 10.0 mL of brain heart infusion (BHI KASVI) and incubated for 18 h at 35-37 °C.…”
Section: Determination Of the Minimal Inhibitory Concentration (Mic)mentioning
confidence: 99%
“…A literature reported procedure with minor modifications was used to synthesise Ag (I) complex of FSE (Ag-FSE) [12]. In brief, a solution of AgNO 3 (0.362 g, 2.13 mmol) in water (2 ml) was added dropwise to a methanolic solution (20 ml) of FSE (0.704 g, 2.13 mmol) and KOH (0.119 g, 2.13 mmol) under stirring.…”
Section: Synthesis Of Ag-fse (Fig 1)mentioning
confidence: 99%
“…Recently, researchers have synthesised an Ag complex of furosemide (FSE), a diuretic and antihypertensive drug, and evaluated it for antimicrobial activity. The studies revealed that FSE-Ag complex (Ag-FSE) could be a good antibacterial drug for future use in medicine [12]. However, the synthesised Ag-FSE is highly insoluble in water and most of the organic solvents.…”
Section: Introductionmentioning
confidence: 99%
“…Silver, copper, zinc and iron are metals which form complexes with furosemide for different purposes. For example, silver‐furosemide complexes showed anti‐bacterial activity against Gram‐positive such as Staphylococcus aureus and Gram negative such as Escherichia coli and Pseudomanas aeruginosa . The complexation of furosemide with copper(II) and Fe(III) chloride were also used for the determination of furosemide content …”
Section: Introductionmentioning
confidence: 99%